Press Releases

PMC press releases highlight the significance of the Coalition’s activities in education, advocacy, and evidence development.

The Personalized Medicine Coalition (PMC), a 501(c)3-designated nonprofit organization supported by more than 200 businesses, patient advocacy groups, and care delivery institutions, is pleased to announce Amy Nicole Nayar, Pharm.D., M.S., as the Coalition’s next President and CEO.


Representatives From Change Healthcare, Flatiron Health, and Tempus to Discuss Significance of Paper’s Recommendations at 12:00 p.m. ET


Acknowledging Enhanced Benefits of Multi-Gene Testing, Modernized Definition Could Prompt Changes in Clinical Use of Genomic Sequencing-Based Tests


Multi-factorial Assessment Finds Majority of Health Care Providers Integrating Personalized Medicine into Clinical Care


Report: Agency’s Policies Reinforcing Shift Toward Personalized Medicine Even in Midst of Pandemic


Understanding Genomic Testing Utilization and Coverage in the US Points to Broader Range of Administrative, Educational, Technical Challenges Complicating Efforts to Integrate Genomic Testing into Clinical Work Streams


Treatments Underscore Promise of New Era in Personalized Medicine Characterized by Ability to Alter Molecular Characteristics of Patients’ Own Cells


PMC President: Report reminds us that personalized medicine offers new hope to patients, opportunities to avoid unsafe or ineffective treatment plans